Table of Contents
ISRN Dermatology
Volume 2012, Article ID 702714, 5 pages
http://dx.doi.org/10.5402/2012/702714
Clinical Study

Treatment of Primary Axillary Hyperhidrosis with Botulinum Toxin Type A: Our Experience in 50 Patients from 2007 to 2010

Plastic Surgery Unit, Circolo and Fondazione Macchi Hospital, University of Insubria, Viale Borri 57, 21100 Varese, Italy

Received 11 June 2012; Accepted 4 July 2012

Academic Editors: K. Saga and P. D. Shenefelt

Copyright © 2012 Stefano Scamoni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. P. Stolman, “Treatment of hyperhidrosis. Review,” Journal of Drugs in Dermatology, vol. 2, no. 5, pp. 521–527, 2003, Erratum in: Journal of Drugs in Dermatology, vol. 2, no. 6, pp. 619, 2003. View at Google Scholar
  2. J. L. Atkins and P. E. M. Butler, “Hyperhidrosis: a review of current management,” Plastic and Reconstructive Surgery, vol. 110, no. 1, pp. 222–228, 2002. View at Google Scholar · View at Scopus
  3. H. Hamm, M. K. Naumann, J. W. Kowalski, S. Kütt, C. Kozma, and C. Teale, “Primary focal hyperhidrosis: disease characteristics and functional impairment,” Dermatology, vol. 212, no. 4, pp. 343–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Haider and N. Solish, “Hyperhidrosis: an approach to diagnosis and management,” Dermatology Nursing, vol. 16, no. 6, pp. 515–517, 2004. View at Google Scholar · View at Scopus
  5. M. Hashmonai, D. Kopelman, and A. Assalia, “The treatment of primary palmar hyperhidrosis: a review,” Surgery Today, vol. 30, no. 3, pp. 211–218, 2000. View at Google Scholar · View at Scopus
  6. M. S. Absar and M. Onwudike, “Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis,” Dermatologic Surgery, vol. 34, no. 6, pp. 751–755, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. R. Strutton, J. W. Kowalski, D. A. Glaser, and P. E. Stang, “US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey,” Journal of the American Academy of Dermatology, vol. 51, no. 2, pp. 241–248, 2004. View at Google Scholar · View at Scopus
  8. S. Reinauer, A. Neusser, G. Schauf, and E. Holzle, “Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis,” British Journal of Dermatology, vol. 129, no. 2, pp. 166–169, 1993. View at Google Scholar · View at Scopus
  9. K. T. Scholes, K. D. Crow, and J. P. Ellis, “Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate,” The British Medical Journal, vol. 2, no. 6130, pp. 84–85, 1978. View at Google Scholar · View at Scopus
  10. E. Hölzle and O. Braun-Falco, “Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution,” British Journal of Dermatology, vol. 110, no. 4, pp. 399–403, 1984. View at Google Scholar · View at Scopus
  11. R. M. Greenhalgh, D. S. Rosengarten, and P. Martin, “Role of sympathectomy for hyperhidrosis,” The British Medical Journal, vol. 1, no. 5744, pp. 332–334, 1971. View at Google Scholar · View at Scopus
  12. M. Heckmann, A. O. Ceballos-Baumann, and G. Plewig, “Botulinum toxin A for axillary hyperhidrosis (excessive sweating),” The New England Journal of Medicine, vol. 344, no. 7, pp. 488–493, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Naumann and N. J. Lowe, “Botulinum toxin type a in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial,” The British Medical Journal, vol. 323, no. 7313, pp. 596–599, 2001. View at Google Scholar · View at Scopus
  14. C. Swartling, H. Naver, and M. Lindberg, “Botulinum A toxin improves life quality in severe primary focal hyperhidrosis,” European Journal of Neurology, vol. 8, no. 3, pp. 247–252, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Salmanpoor and M. J. Rahmanian, “Treatment of axillary hyperhidrosis with botulinum-A toxin,” International Journal of Dermatology, vol. 41, no. 7, pp. 428–430, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Galadari and J. Alkaabi, “Botulinum toxin in the treatment of axillary hyperhidrosis,” Skinmed, vol. 2, no. 4, pp. 209–211, 2003. View at Google Scholar · View at Scopus
  17. I. R. Odderson, “Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis,” Dermatologic Surgery, vol. 28, no. 6, pp. 480–483, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Naver, C. Swartling, and S. M. Aquilonius, “Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up,” European Journal of Neurology, vol. 7, no. 1, pp. 55–62, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Schnider, M. Binder, H. Kittler et al., “A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis,” British Journal of Dermatology, vol. 140, no. 4, pp. 677–680, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. S. R. Tan and N. Solish, “Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A,” Dermatologic Surgery, vol. 28, no. 6, pp. 495–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Wollina, T. Karamfilov, and H. Konrad, “High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval,” Journal of the American Academy of Dermatology, vol. 46, no. 4, pp. 536–540, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. J. Whatling and M. J. Collin, “Botulinum toxin injection is an effective treatment for axillary hyperhidrosis,” British Journal of Surgery, vol. 88, no. 6, pp. 814–815, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Heckmann, S. Breit, A. Ceballos-Baumann, M. Schaller, and G. Plewig, “Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis,” Journal of the American Academy of Dermatology, vol. 41, no. 6, pp. 987–990, 1999. View at Google Scholar · View at Scopus
  24. M. Heckmann and G. Plewig, “Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study,” Archives of Dermatology, vol. 141, no. 10, pp. 1255–1259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. O. Bushara, D. M. Park, J. C. Jones, and H. S. Schutta, “Botulinum toxin—a possible new treatment for axillary hyperhidrosis,” Clinical and Experimental Dermatology, vol. 21, no. 4, pp. 276–278, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Campanati, L. Penna, T. Guzzo et al., “Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study,” Clinical Therapeutics, vol. 25, no. 1, pp. 298–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. M. Cheng, J. S. Chen, and R. P. Patel, “Unlabeled uses of botulinum toxins: a review, part 1,” American Journal of Health-System Pharmacy, vol. 63, no. 2, pp. 145–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Naumann, N. J. Lowe, C. R. Kumar, and H. Hamm, “Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study,” Archives of Dermatology, vol. 139, no. 6, pp. 731–736, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. D. Whelchel, T. M. Brehmer, P. M. Brooks, N. Darragh, and J. A. Coffield, “Molecular targets of botulinum toxin at the mammalian neuromuscular junction,” Movement Disorders, vol. 19, no. 8, supplement, pp. S7–S16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Breidenbach and A. T. Brunger, “New insights into clostridial neurotoxin-SNARE interactions,” Trends in Molecular Medicine, vol. 11, no. 8, pp. 377–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Steiner, “Quantitative sweats test: iodine-starch and gravimetry,” in Hyperhidrosis and Botulinum Toxin, A. R. T. Almeida and D. M. Hexsel, Eds., pp. 59–61, Edition of Authors, Sao Paulo, Brazil, 2004. View at Google Scholar
  32. D. Hexsel, T. C. Rodrigues, M. Soirefmann, and D. Zechmeister-Prado, “Recommendations for performing and evaluating the results of the minor test according to a sweating intensity visual scale,” Dermatologic Surgery, vol. 36, no. 1, pp. 120–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. P. L. Lowe, S. Cerdan-Sanz, and N. J. Lowe, “Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments,” Dermatologic Surgery, vol. 29, no. 5, pp. 545–548, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Hornberger, K. Grimes, M. Naumann et al., “Recognition, diagnosis, and treatment of primary focal hyperhidrosis,” Journal of the American Academy of Dermatology, vol. 51, no. 2, pp. 274–286, 2004. View at Google Scholar · View at Scopus
  35. A. Haider and N. Solish, “Focal hyperhidrosis: diagnosis and management,” Canadian Medical Association Journal, vol. 172, no. 1, pp. 69–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Solish, A. Benohanian, and J. W. Kowalski, “Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life,” Dermatologic Surgery, vol. 31, no. 4, pp. 405–413, 2005. View at Google Scholar · View at Scopus
  37. N. J. Lowe, D. A. Glaser, N. Eadie, S. Daggett, J. W. Kowalski, and P. Y. Lai, “Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety,” Journal of the American Academy of Dermatology, vol. 56, no. 4, pp. 604–611, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. W. Kowalski, N. Eadie, S. Dagget, and P. Y. Lai, “Validity and reliability of the Hyperhidrosis Disease Severity Scale (HDSS),” Journal of the American Academy of Dermatology, vol. 50, no. 3, p. P51, 2004. View at Google Scholar
  39. A. Weber, S. Heger, R. Sinkgraven, M. Heckmann, P. Elsner, and B. Rzany, “Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A,” British Journal of Dermatology, vol. 152, no. 2, pp. 342–345, 2005. View at Publisher · View at Google Scholar · View at Scopus